Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Testing centre queues fuel criticism over France's COVID strategy

Published 05/08/2020, 15:14
Updated 05/08/2020, 15:16
© Reuters. People queue to enter a laboratory to get tested for the coronavirus disease (COVID-19) in Neuilly-sur-Seine, near Paris

PARIS (Reuters) - The French government was under fire on Wednesday over its free-for-all COVID-19 testing policy as queues snaked out of some testing centres in Paris and at sites across the country amid a flare-up in infections.

One leading federation of laboratories said an abrupt July 25 decree to make testing free-of-charge and without prescription piled pressure on at a time many staff go on holiday. Political opponents lampooned a policy in disarray.

"Testing anyone achieves nothing. You have to be targeted," epidemiologist Didier Pittet, who heads a government-appointed task force monitoring the handling of COVID-19, told Europe 1 radio.

France, like many of its European neighbours, is witnessing a mushrooming of new coronavirus clusters.

The number of COVID-19 patients in intensive care rose for the second straight day on Tuesday, reversing a 16-week downward trend. The disease has killed more than 30,000 people in France.

France is now testing some 576,000 people per week, an Health Ministry spokesman told Reuters on Wednesday, compared with 200,000 when President Emmanuel Macron began easing one of Europe's strictest lockdowns.

The strategy is working, health minister Olivier Veran said over the weekend. "The virus is no longer tracking us, we are tracking it," he told Le Parisien.

The ministry's spokesman acknowledged "localized problems" but was adamant that France had chosen the right strategy.

But Lionel Barrand, who heads the Syndicat National des Jeunes Biologistes federation, said the open testing strategy amounted to hunting for a needle in a haystack and put laboratories under strain.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"The government threw sand in our wheels. It sent a lot of people to labs without prior warning," Barrand told Reuters.

Frustrated by the reluctance of some laboratories to invest in the manpower and operational changes needed to conduct testing, the government had considered requisitioning some of them, one government official said.

Latest comments

Meanwhile back on planet earth.... Bond yields have plummeted continuously over 30 years and stocks are still in massive bubble from Fed continuous QE and will at some point have to find true value based on reality. And when will these guys learn from history that once debt to GDP goes over 90% that the game is already over for the currency in which the stocks are denominated. The share buy backs have endebted the businesses and if they are not actually bankrupt then they are very overvalued. Gold is not an investment but a safe place to store value whilst the world works out real value and with enormous asset, property overvaluation and central banks trying to desperately find an extra few yards to kick the can down the road the inevitable correction will come like it or not.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.